Intervention Review

Treatment for Lambert-Eaton myasthenic syndrome

  1. Michael Keogh1,*,
  2. Saam Sedehizadeh2,
  3. Paul Maddison2

Editorial Group: Cochrane Neuromuscular Group

Published Online: 16 FEB 2011

Assessed as up-to-date: 11 OCT 2010

DOI: 10.1002/14651858.CD003279.pub3


How to Cite

Keogh M, Sedehizadeh S, Maddison P. Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD003279. DOI: 10.1002/14651858.CD003279.pub3.

Author Information

  1. 1

    Newcastle University, Institute of Human Genetics, Centre for Life, Newcastle upon Tyne, UK

  2. 2

    Queen's Medical Centre, Department of Neurology, D Floor, West Block, Nottingham, UK

*Michael Keogh, Institute of Human Genetics, Centre for Life, Newcastle University, Newcastle upon Tyne, UK. michael.keogh@ncl.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 16 FEB 2011

SEARCH

  1. Current Version

    Treatment for Lambert-Eaton myasthenic syndrome

    Michael Keogh, Saam Sedehizadeh and Paul Maddison

    Version of Record online: 16 FEB 2011 | DOI: 10.1002/14651858.CD003279.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Treatment for Lambert-Eaton myasthenic syndrome

    Paul Maddison and John Newsom-Davis

    Version of Record online: 20 APR 2005 | DOI: 10.1002/14651858.CD003279.pub2

  2. Version 1

    Treatment for Lambert-Eaton myasthenic syndrome

    P Maddison and J Newsom-Davis

    Version of Record online: 22 APR 2003 | DOI: 10.1002/14651858.CD003279